Table 2.
Production of IFN-γ against Leishmania (Leish) antigens A, B, or C by volunteers in areas of Iran endemic for ZCL, ZVL, and ACL*
Area | IFN-γ to mitogen | IFN-γ to Leish C | IFN-γ to Leish B | IFN-γ to Leish A |
---|---|---|---|---|
ZCL-1 | 14.901 ± 0.40 | – | 1.813 ± 0.369 | 1.573 ± 0.316 |
ZCL-2 | 18.444 ± 1.419 | 1.104 ± 0.230 | – | 1.000 ± 0.169† |
ACL | 17.069 ± 0.643 | 1.464 ± 0.482 | – | 1.454 ± 0.559 |
ZVL | 19.551 ± 0.856 | 2.238 ± 0.551 | – | 2.664 ± 0.606† |
Values are mean ± SE (IU/mL). IFN-γ = interferon-γ; ZCL = zoonotic cutaneous leishmaniasis; ACL = anthroponotic cutaneous leishmaniasis; ZVL = zoonotic visceral leishmaniasis.
A statistically significant difference was shown between IFN-γ production against Leish Aantigen between persons who were cured of ZVL and healed cases of ZCL-2 (P = 0.029).